3 Stocks I Saw on T...
Health Care: Drugs
XTL Biopharmaceuticals Limited (XTLB: NASDAQ)
$0.08 -0.05 | -37.69%
04/16/09 - 03:59 PM ET
5.48M / 486.60K
Vol / Avg. Vol:0.12 / 0.13
Open / Prev. Close:0.05 - 0.12
Today's Range:0.04 - 4.96
52 Wk Range:58.20%
Performance YTD:TheStreet Rating:
Portfolios with XTLB
- Portfolio NameUser Type
- UserBarron's Insider Purchases ...
- Usersconyers09 Portfolio 1
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserCoastal ProTrade 1
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
Latest XTLB Headlines from TheStreet
- Ecolab Insider Sells $827.7 Million Worth 12.04.08 | 09:12 am
- Monday's Small-Cap Winners & Losers 09.10.07 | 04:09 pm
- Tuesday's Small-Cap Winners & Losers 06.20.07 | 12:06 am
- Wednesday's Small-Cap Winners & Losers 06.06.07 | 04:06 pm
- Israeli Options Index Nears 05.23.06 | 04:05 pm
Press Releases for XTLB
- XTL Biopharmaceuticals Ltd. Names Dr. Ben-Zion Weiner To Its Board Of Directors - PR Newswire 04.17.12 | 10:04 am
- XTL Biopharmaceuticals Ltd. Signs Letter Of Intent To Acquire A Drug Development Company - PR Newswire 04.16.12 | 04:04 pm
- XTL Biopharmaceuticals Reports Full-Year 2011 Results - PR Newswire 03.29.12 | 06:03 pm
- XTL Biopharmaceuticals Successfully Completes A Capital Raise In Israel Of Approximately $3.5 Million Led By Institutional Investors - PR Newswire 03.19.12 | 08:03 am
- XTL Bio Signs Strategic Collaboration Framework Agreement With Clalit Research Institute And Mor Research Applications - PR Newswire 03.15.12 | 02:03 pm
- XTL Biopharmaceuticals, Ltd. Completes The Acquisition Of MinoGuard - PR Newswire 11.30.11 | 02:11 pm
- XTL Biopharmaceuticals To Acquire NiCure - PR Newswire 11.03.11 | 05:11 pm
Partner Headlines for XTLB
